Juniper Biologics In-Licenses Helsinn’s Oncology Portfolio
Lugano, Switzerland – Singapore, 22 December, 2021 – Helsinn Healthcare SA (“Helsinn”), a fully integrated, global biopharma company with a diversified pipeline of innovative oncology assets
Hello There!
Lorem ipsum dolor sit amet, consectetur adipiscing elit,
